Pluri Inc. (PLUR)
NASDAQ·Healthcare·Biotechnology
$2.33
+3.33%
Mkt Cap $27.51M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+416.1%
Consensus $12.00 vs current $2.33
NASDAQ·Healthcare·Biotechnology
$2.33
+3.33%
Mkt Cap $27.51M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+416.1%
Consensus $12.00 vs current $2.33